Intech Biopharm Corporation (6461.TWO)
6461.TWO Stock Price Chart
Explore Intech Biopharm Corporation interactive price chart. Choose custom timeframes to analyze 6461.TWO price movements and trends.
6461.TWO Company Profile
Discover essential business fundamentals and corporate details for Intech Biopharm Corporation (6461.TWO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Jul 2014
Employees
90.00
Website
https://www.intechbiopharm.comCEO
Wei-Shiu Wu
Description
Intech Biopharm Corporation engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and COPD; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
6461.TWO Financial Timeline
Browse a chronological timeline of Intech Biopharm Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Stock split effective on 26 Sept 2023
Shares were split 513:500, changing the number of shares outstanding and the price per share accordingly.
6461.TWO Stock Performance
Access detailed 6461.TWO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.